BrainChild Bio, Inc., a clinical-stage biotechnology company developing CAR T-cell therapies to treat tumors in the central nervous system (CNS), today announced the clinical development plan to ...
According to GlobalData, Phase II drugs for Low-Grade Glioma have a 64% phase transition success rate (PTSR ... FORE8394 is a small molecule that only targets cancer cells with a mutated BRAF gene.
INR:6953. live score 18 Affected by the epidemic, some companies cut wages The power of centralized procurement has just begun to show that Yuheng Pharmaceutical wi ...
PokerBaazi review Researchers find that targeting stromal cells can overcome glioma drug resistance Bio-Thera's stock price rose 83.15% on its first d ...
A new fertility technology developed by Gameto, using stem cells to help embryos mature outside the body, has led to the world’s first live human birth. This new technique, called Fertilo ...